Cytokinetics | CYTK - Market Capitalization


Cytokinetics reported $8.71B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.33B 537M Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
Arca Biopharma USD 2.43B 963M Mar/2026
Bayer EUR 47.56B 8.87B Jun/2026
Biogen USD 31.9B 5B Jun/2026
Brainstorm Cell Therapeutics USD 11M 3M Mar/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Capricor Therapeutics USD 1.66B 1.33B Dec/2025
Cytokinetics USD 11.55B 3.36B Jun/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
Exelixis USD 13.54B 2.65B Jun/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026